Case Report

IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis

Volume 48 · Issue 2 · January 2016 Publish Date: September 3, 2019
Full Text PDF
DOI
Sevket Arslan
Division of Immunology and Allergic Disease
Ramazan Ucar
Division of Immunology and Allergic Disease
Ahmet Zafer Caliskaner
Division of Immunology and Allergic Disease
Arslan, S., Ucar, R., & Caliskaner, A. Z. (2019). IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis. The Eurasian Journal of Medicine, 48(2), 145–148. https://doi.org/10.5152/eurasianjmed.2015.0024
Full Text Full Text PDF

Abstract

Abstract

Metamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin® ampoule; Sanofi Aventis, İstanbul, Turkey) and discuss the mechanism underlying the reaction.

Similar Articles

Article Info
Published In
Journal The Eurasian Journal of Medicine
Volume / Issue Volume 48 · Issue 2 · January 2016
Pages 145-148
History
Published Online September 3, 2019
Copyright
Affiliations
Sevket Arslan
Division of Immunology and Allergic Disease
Ramazan Ucar
Division of Immunology and Allergic Disease
Ahmet Zafer Caliskaner
Division of Immunology and Allergic Disease
Cite this Article
Arslan, S., Ucar, R., & Caliskaner, A. Z. (2019). IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis. The Eurasian Journal of Medicine, 48(2), 145–148. https://doi.org/10.5152/eurasianjmed.2015.0024
Share
Outlines